COCRYSTAL PHARMA, INC. Finance Lease, Liability, Current
COCRYSTAL PHARMA, INC. (COCP) had Finance Lease, Liability, Current of $7.00 thousand as of 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2024-03-28
- 2022-12-31: Finance Lease, Liability, Current $7.00K.
- 2022-09-30: Finance Lease, Liability, Current $14.00K.
- 2022-06-30: Finance Lease, Liability, Current $21.00K.
- 2022-03-31: Finance Lease, Liability, Current $28.00K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2022-12-31 | $7.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $14.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $21.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $28.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $27.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $29.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $33.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $36.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $39.00K 10-K · filed 2022-03-23 |
| 2020-09-30 | $40.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $39.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $50.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $103.00K 10-K · filed 2021-03-17 |
| 2019-09-30 | $154.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $204.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $218.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $214.00K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |